Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex - Ebrahimi-Fakhari, D; Agricola, KD; Tudor, C (Pediatr Neurol, 2020)
et al.